Mucormycosis is a severe, potentially fatal invasive fungal infection that arises in immunocompromised persons, typically starting in the nasal passages and paranasal sinuses after inhaling fungal spores. It is triggered by fungi belonging to the Mucorales order and the Mucoraceae family. This infection frequently occurs in the rhinomaxillary area and individuals with weakened immune systems, like those with diabetes. Thus, early detection of this possibly fatal illness and timely intervention is crucial in lowering the death rate.
Chakrabarti A, Chatterjee SS, Das A, et al. Invasive zygomycosis in India: Experience in a tertiary care hospital. Postgrad Med J 2009;85:573–581. DOI: 10.1136/pgmj.2008.076463.
Chakrabarti A, Chatterjee SS, Das A, et al. Invasive aspergillosis in developing countries. Med Mycol 2011;49(Suppl 1):S35–S47. DOI: 10.3109/13693786.2010.505206.
Lass-Florl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009;52:197–205. DOI: 10.1111/j.1439-0507.2009.01691.x.
Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol 2010;28:197–201. DOI: 10.1016/j.clindermatol.2009.12.005.
Nucci M, Queiroz-Telles F, Tobon AM, et al. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010;51:561–570. DOI: 10.1086/655683.
Meis JF, Chakrabarti A. Changing epidemiology of an emerging infection: zygomycosis. Clin Microbiol Infect 2009;15(Suppl 5):10–14. DOI: 10.1111/j.1469-0691.2009.02973.x.
Binder U, Lass-Florl C. Epidemiology of invasive fungal infections in Mediterranean area. Mediterr J Hematol Infect Dis 2011;3:e20110016. DOI: 10.4084/mjhid.2011.0016.
Chatterjee SS, Chakrabarti A. Epidemiology and medical mycology of fungal rhinosinusitis. Otorhinolaryngol Clin: An Int J 2009;1:1–13. 9. DOI: 10.5005/jp-journals-10003-1001.
Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res 2011;36:179–189. DOI: 10.3109/02713683.2010.533810.
Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev 2010;23:884–928. DOI: 10.1128/CMR.00019-10.
Queiroz-Telles F, Nucci M, Colombo AL, et al. Mycoses of implantation in Latin America: An overview of epidemiology, clinical manifestations, diagnosis and treatment. Med Mycol 2011;49:225–236. DOI: 10.3109/13693786.2010.539631.
Pagano L, Akova M, Dimopoulos G, et al. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011;66(Suppl 1):i5–14. DOI: 10.1093/jac/dkq437.
Mantadakis E, Samonis G. Clinical presentation of zygomycosis. Clin Microbiol Infect 2009;15(Suppl 5):15–20. 10.1111/j.1469-0691.2009.02974.x
Marx RE, Stern D. Inflammatory, reactive and infectious diseases. In: Marx RE, Stern D, editors. Oral & Maxillofacial Pathology. Carol Stream, Ill, USA: Quintessence Publishing; 2003. pp. 104–106.
Kajs-Wyllie M. Hyperbaric oxygen therapy for rhinocerebral fungal infection. J Neurosci Nurs 1995;27:174–181. DOI: 10.1097/01376517-199506000-00006.
Lador N, Polacheck I, Gural A, et al. A trifungal infection of the mandible: Case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:451–456. DOI: 10.1016/j.tripleo.2005.07.022.
